Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

WAT stock hub

Waters Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

WATis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
34.9B
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
WAT
In the news

Latest news · WAT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.7
P25 12.3P50 18.4P75 33.1
Trailing P/E51.6
P25 14.9P50 23.2P75 38.5
ROE5.2
P25 -105.6P50 -46.5P75 -3.1
ROIC6.4
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All WAT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
257
Groups with data
11
Currency
USD
Showing 257 of 257 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

26
MetricValue
Cik
0001000697
Company name
Waters Corporation
Country
United States
Country code
US
Cusip
941848103
Employees
7,900
Employees Change
300%
Employees Change Percent
3.95
Enterprise value
$39.6B
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
In Index
SP500
Industry
Diagnostics & Research
IPO Date
1995-11-16
Isin
US9418481035
Last refreshed
2026-05-10
Market cap
$34.9B
Market cap category
Large-Cap
Price
$355
Price currency
USD
Rev Per Employee
477,251.39x
Sector
Healthcare
Sic
3826
Symbol
WAT
Website
https://www.waters.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

17
MetricValue
Earnings Yield
1.29%
EV Earnings
88.1x
EV Sales Forward
5.77x
EV/EBIT
45.08x
EV/EBITDA
31.87x
EV/FCF
150.16x
EV/Sales
10.51x
FCF yield
0.76%
Forward P/E
23.66x
P/B ratio
1.91x
P/E ratio
51.57x
P/S ratio
9.25x
PE Ratio10 Y
73.64x
PE Ratio3 Y
33.54x
PE Ratio5 Y
31.69x
PEG ratio
2.09x
PS Forward
5.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
23.31%
EBITDA Margin
32.97%
FCF margin
7%
Gross margin
57.97%
Gross Profit
$2.2B
Gross Profit Growth
23.61%
Gross Profit Growth Q
80.28%
Gross Profit Growth3 Y
8.33%
Gross Profit Growth5 Y
8.42%
Net Income
$449.6M
Net Income Growth
-31.57%
Net Income Growth Years
1%
Net Income Growth3 Y
-13.26%
Net Income Growth5 Y
-6.11%
Pretax Margin
13.89%
Profit Margin
11.93%
Profit Per Employee
$56,915
Profitable Years
28
ROA
3.77
Roa5y
14.31
ROE
5.21
Roe5y
108.6
ROIC
6.4
Roic5y
35.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr10y
10.34%
Cagr15y
9.05%
Cagr1y
2.8%
Cagr20y
10.81%
Cagr3y
6.16%
Cagr5y
2.45%
EPS Growth
-37.49
EPS Growth Years
1
EPS Growth3 Y
-15.72
EPS Growth5 Y
-6.96
FCF Growth
-57.4%
FCF Growth3 Y
-14.89%
FCF Growth5 Y
-17.65%
OCF Growth
-48.66%
OCF Growth10 Y
-3.69%
OCF Growth3 Y
-13.91%
OCF Growth5 Y
-14.59%
Revenue Growth
26.38x
Revenue Growth Q
91.48x
Revenue Growth Quarters
6x
Revenue Growth Years
2x
Revenue Growth3 Y
8.33x
Revenue Growth5 Y
8.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
$0.26
Assets
$24.5B
Cash
$462M
Current Assets
$3.7B
Debt
$5.2B
Debt EBITDA
$4.2
Debt Equity
$0.34
Debt FCF
$19.77
Equity
$15.3B
Interest Coverage
8.33
Liabilities
$9.2B
Long Term Assets
$20.8B
Net Cash
$-4.8B
Net Cash By Market Cap
$-13.63
Net Debt EBITDA
$3.82
Net Debt Equity
$0.31
Net Debt FCF
$18.02
Tangible Book Value
$-2.8B
Tangible Book Value Per Share
$-34.14
WACC
9.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

3
MetricValue
Inventory Turnover
1.58
Working Capital
$3.7B
Working Capital Turnover
$1.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-9.55%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

42
MetricValue
10Y total return
167.4%
1Y total return
2.8%
200-day SMA
336.1
3Y total return
19.66%
50-day SMA
311
50-day SMA vs 200-day SMA
50under200
5Y total return
12.87%
All Time High
428.2
All Time High Change
-17.07%
All Time High Date
2021-09-08
All Time Low
3.31
All Time Low Change
10,619.29%
All Time Low Date
1995-11-28
ATR
14.03
Beta
1.14
Beta1y
0.98
Beta2y
0.69
Ch YTD
-6.5
High
357
High52
414.2
High52 Date
2025-11-25
High52ch
-14.25%
Low
339.2
Low52
275.1
Low52 Date
2025-08-08
Low52ch
29.12%
Ma50ch
14.18%
Premarket Change Percent
-0.28
Premarket Price
$350
Premarket Volume
118
Price vs 200-day SMA
5.65%
RSI
66.71
RSI Monthly
52.74
RSI Weekly
54.44
Sharpe ratio
0.16x
Sortino ratio
0.37
Total Return
-9.55%
Tr YTD
-6.5
Tr15y
266.61%
Tr1m
15.54%
Tr1w
15.63%
Tr3m
-6.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

18
MetricValue
Analyst Count
16
Analyst Count Top
1
Analyst Price Target Top
$385
Analyst Ratings
Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$2.31
Earnings EPS Estimate Growth
2.67
Earnings Revenue Estimate
1,202,595,696x
Earnings Revenue Estimate Growth
81.74x
Operating Income
$878.8M
Operating Income Growth
3.98
Operating Income Growth Q
-2.47
Operating Income Growth3 Y
1.02
Operating Income Growth5 Y
2.84
Operating margin
23.31
Price target
$386
Price Target Change
$8.73
Price Target Change Top
$8.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
98,023,538%
Float Percent
99.86%
Net Borrowing
-220,000,000
Shares Insiders
0.08%
Shares Institutions
77.84%
Shares Out
98,165,491
Shares Qo Q
37.44%
Shares Yo Y
9.55%
Short Float
3.81%
Short Ratio
3.89
Short Shares
3.8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

71
MetricValue
Adjusted FCF
$202.7M
Average Volume
1,114,277.85x
Bv Per Share
186.2
CAPEX
$-125.7M
Ch10y
167.4
Ch15y
266.6
Ch1m
15.54
Ch1w
15.63
Ch1y
2.8
Ch20y
679.3
Ch3m
-6.86
Ch3y
19.66
Ch5y
12.87
Ch6m
-4.46
Change
1.32%
Change From Open
1.72
Close
350.5
Days Gap
-0.39
Depreciation Amortization
364,237,000
Dollar Volume
644,220,380.3
Earnings Date
2026-05-05
Earnings Time
bmo
EBIT
$878.8M
EBITDA
$1.2B
EPS
$6.89
F Score
3
FCF
$263.8M
FCF EV Yield
0.67x
FCF Per Share
$2.69
Financing CF
-277,205,000
Fiscal Year End
December
Founded
1,958
Goodwill
9,317,000,000
Graham Number
169.84017
Graham Upside
-52.18
Income Tax
$74.2M
Investing CF
-31,253,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-05
Last Report Date
2026-04-04
Last Split Date
2000-08-28
Last Split Type
Forward
Last10k Filing Date
2026-02-23
Lynch Fair Value
$34.43
Lynch Upside
-90.3
Ma150
349.4
Ma150ch
1.63%
Ma20
323.2
Ma20ch
9.88%
Net CF
78,476,000
Next Earnings Date
2026-08-03
Open
349.1
Optionable
Yes
P FCF Ratio
132.1
P OCF Ratio
89.49
Position In Range
89.57
Ppne
1,520,000,000
Pre Close
350.5
Price Date
2026-05-08
Price EBITDA
$28.05
Relative Volume
1.63x
Revenue
3,770,286,000x
SBC By Revenue
1.62x
Share Based Comp
61,127,000
Tax By Revenue
1.97x
Tax Rate
14.17%
Tr20y
679.31%
Tr6m
-4.46%
Us State
Massachusetts
Volume
1,814,041
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does WAT pay a dividend?

Capital-return profile for this ticker.

Performance

WAT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+2.8%
S&P 500 1Y: n/a
3Y total return
+19.7%
S&P 500 3Y: n/a
5Y total return
+12.9%
S&P 500 5Y: n/a
10Y total return
+167.4%
S&P 500 10Y: n/a
Ownership

Who owns WAT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+77.8%
Float: +99.9% of shares outstanding
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+3.8%
3.9 days to cover
Y/Y dilution
+9.5%
Negative means the company is buying back shares.
Technical

WAT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
66.7
Neutral momentum band
Price vs 200-day MA
+5.7%
50/200-day relationship not available
Beta (5Y)
1.14
Moves roughly with the market
Sharpe ratio
0.16
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About WAT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current WAT stock rating?

Waters Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full WAT analysis?

The full report lives at /stocks/WAT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for WAT?

The latest report frames WAT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the WAT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.